dactinomycin has been researched along with Salivary Gland Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agaoglu, L; Anak, S; Bilgic, B; Celik, A; Devecioglu, O; Gulluoglu, M; Karakas, Z; Saribeyoglu, ET; Unuvar, A | 1 |
1 other study(ies) available for dactinomycin and Salivary Gland Neoplasms
| Article | Year |
|---|---|
How to manage an unresectable or recurrent sialoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Dactinomycin; Disease Management; Humans; Infant, Newborn; Male; Neoplasm Recurrence, Local; Salivary Gland Neoplasms; Salvage Therapy; Treatment Outcome; Vincristine | 2010 |